Insider Transactions Reported by 26 Insiders of Apellis Pharmaceuticals, Inc.

Symbol
APLS on Nasdaq
Location
Waltham, MA

Insiders trading volume in the past year

Apellis Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Morningside Venture Investments Ltd 10%+ Owner $815,635,922 18 Nov 2021
Cedric Francois Chief Executive Officer, Director $45,380,584 -$10,544,358 -19% 11 Mar 2026
Pascal Deschatelets Chief Scientific Officer $31,171,609 -$197,537 -0.63% 28 Jan 2026
Alec Machiels Director $19,212,760 01 Jan 2026
Lukas Scheibler Chief Research Officer $6,961,586 01 Dec 2023
Timothy Eugene Sullivan Chief Financial Officer $6,936,113 -$1,837,126 -21% 28 Jan 2026
Watson David O General Counsel $6,740,578 -$1,672,246 -20% 28 Jan 2026
Federico Grossi Chief Medical Officer $6,043,162 05 Jan 2023
Nur Nicholson Chief Technical Officer $4,522,097 -$269,828 -5.6% 28 Jan 2026
Kelley Boucher Chief People Officer $4,517,257 28 Jan 2026
Mark Jeffrey DeLong Chief Business & Strat Officer $4,138,289 -$147,421 -3.4% 11 Feb 2026
A. Sinclair Dunlop Director $3,817,828 -$2,153,155 -36% 01 Jan 2026
Caroline Baumal Chief Medical Officer $3,482,969 -$175,225 -4.8% 22 Jan 2026
Leslie Meltzer Chief Research and Development $2,688,453 28 Jan 2026
Adam J. Townsend Chief Commercial Officer $2,481,459 29 Jan 2025
Karen Lewis Chief People Officer $2,074,062 29 Jan 2025
James George Chopas VP/Chief Accounting Officer $1,874,933 -$98,621 -5% 28 Jan 2026
Jeffrey Eisele Chief Development Officer $1,633,009 29 Jan 2025
Victoria L. Brown Program Team Lead $1,500,282 20 Jan 2023
Paul R. Fonteyne Director $1,105,729 01 Jan 2026
Craig A. Wheeler Director $1,090,760 01 Jan 2026
Stephanie Monaghan O'Brien Director $987,579 01 Jan 2026
Gerald Chan Director $987,579 01 Jan 2026
Keli Walbert Director $910,719 01 Jan 2026
Mikael Dolsten Director $821,448 02 Mar 2026
Nicole D. Perry Vice President - Accounting $717,179 02 Aug 2021

Recent Insider Transactions by Companies or Individuals for Apellis Pharmaceuticals, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Cedric Francois APLS Common Stock Gift 21.1% 64,869 372,815 11 Mar 2026 Indirect Owner (The Cedric Francois Irrevocable Trust of 2023 - 2)
Cedric Francois APLS Common Stock Gift -13.2% -64,869 425,968 11 Mar 2026 Direct
Mikael Dolsten APLS Common Stock Award 14,312 14,312 27 Feb 2026 Direct
Mikael Dolsten APLS Stock Option (Right to Buy) Award 24,135 24,135 27 Feb 2026 Direct
Mark Jeffrey DeLong APLS Common Stock Sale -0.32% $8,153 $22.15 -368 114,591 11 Feb 2026 Direct
Cedric Francois APLS Common Stock Options Exercise 1.83% 8,840 490,837 03 Feb 2026 Direct
Cedric Francois APLS Stock Option (Right to Buy) Options Exercise -100% -8,840 0 03 Feb 2026 Direct
Kelley Boucher APLS Common Stock Award 30.9% 30,146 127,804 28 Jan 2026 Direct
James George Chopas APLS Common Stock Award 32.4% 16,150 65,955 28 Jan 2026 Direct
Mark Jeffrey DeLong APLS Common Stock Award 46.7% 36,606 114,959 28 Jan 2026 Direct
Pascal Deschatelets APLS Common Stock Award 2.24% 25,840 1,177,222 28 Jan 2026 Direct
Leslie Meltzer APLS Common Stock Award 73.2% 45,220 107,024 28 Jan 2026 Direct
Nur Nicholson APLS Common Stock Award 63.6% 45,220 116,338 28 Jan 2026 Direct
Timothy Eugene Sullivan APLS Common Stock Award 61.9% 58,140 152,041 28 Jan 2026 Direct
Watson David O APLS Common Stock Award 63.2% 55,986 144,517 28 Jan 2026 Direct
Cedric Francois APLS Common Stock Award 68.5% 195,952 481,997 28 Jan 2026 Direct
Caroline Baumal APLS Common Stock Sale -3.13% $60,878 $21.77 -2,797 86,527 22 Jan 2026 Direct
James George Chopas APLS Common Stock Sale -3.98% $44,924 $21.77 -2,064 49,805 22 Jan 2026 Direct
Mark Jeffrey DeLong APLS Common Stock Sale -4.12% $73,371 $21.77 -3,371 78,353 22 Jan 2026 Direct
Pascal Deschatelets APLS Common Stock Sale -0.51% $129,025 $21.77 -5,928 1,151,382 22 Jan 2026 Direct
Cedric Francois APLS Common Stock Sale -8.68% $591,845 $21.77 -27,192 286,045 22 Jan 2026 Direct
Nur Nicholson APLS Common Stock Sale -9.8% $168,138 $21.77 -7,725 71,118 22 Jan 2026 Direct
Timothy Eugene Sullivan APLS Common Stock Sale -9.87% $223,901 $21.77 -10,287 93,901 22 Jan 2026 Direct
Watson David O APLS Common Stock Sale -8.13% $170,467 $21.77 -7,832 88,531 22 Jan 2026 Direct
Caroline Baumal APLS Common Stock Sale -2.06% $37,250 $19.79 -1,882 89,324 20 Jan 2026 Direct
James George Chopas APLS Common Stock Sale -1.38% $14,370 $19.79 -726 51,869 20 Jan 2026 Direct
Mark Jeffrey DeLong APLS Common Stock Sale -1.61% $26,404 $19.79 -1,334 81,724 20 Jan 2026 Direct
Pascal Deschatelets APLS Common Stock Sale -0.08% $17,992 $19.79 -909 1,157,310 20 Jan 2026 Direct
Cedric Francois APLS Common Stock Sale -2.55% $161,946 $19.79 -8,182 313,237 20 Jan 2026 Direct
Nur Nicholson APLS Common Stock Sale -2.72% $43,604 $19.79 -2,203 78,843 20 Jan 2026 Direct
Timothy Eugene Sullivan APLS Common Stock Sale -2.7% $57,241 $19.79 -2,892 104,188 20 Jan 2026 Direct
Watson David O APLS Common Stock Sale -2.5% $48,987 $19.79 -2,475 96,363 20 Jan 2026 Direct
James George Chopas APLS Common Stock Sale -1.63% $19,369 $22.19 -873 52,595 13 Jan 2026 Direct
Mark Jeffrey DeLong APLS Common Stock Sale -2.1% $39,493 $22.19 -1,780 83,058 13 Jan 2026 Direct
Pascal Deschatelets APLS Common Stock Sale -0.2% $50,520 $22.19 -2,277 1,158,219 13 Jan 2026 Direct
Cedric Francois APLS Common Stock Sale -3.07% $225,999 $22.19 -10,186 321,419 13 Jan 2026 Direct
Nur Nicholson APLS Common Stock Sale -3.13% $58,086 $22.19 -2,618 81,046 13 Jan 2026 Direct
Timothy Eugene Sullivan APLS Common Stock Sale -3.48% $85,554 $22.19 -3,856 107,080 13 Jan 2026 Direct
Watson David O APLS Common Stock Sale -5.52% $128,242 $22.19 -5,780 98,838 13 Jan 2026 Direct
Watson David O APLS Common Stock Options Exercise 0.86% 888 104,618 07 Jan 2026 Direct
Watson David O APLS Stock Option (Right to Buy) Options Exercise -5.96% -888 14,000 07 Jan 2026 Direct
Caroline Baumal APLS Common Stock Sale -3.21% $77,097 $25.53 -3,020 91,206 05 Jan 2026 Direct
Alec Machiels APLS Common Stock Award 2.11% 7,961 384,989 01 Jan 2026 Direct
Alec Machiels APLS Stock Option (Right to Buy) Award 14,684 14,684 01 Jan 2026 Direct
A. Sinclair Dunlop APLS Common Stock Award 5.18% 7,961 161,567 01 Jan 2026 Direct
A. Sinclair Dunlop APLS Stock Option (Right to Buy) Award 14,684 14,684 01 Jan 2026 Direct
Gerald Chan APLS Common Stock Award 45% 7,961 25,666 01 Jan 2026 Direct
Gerald Chan APLS Stock Option (Right to Buy) Award 14,684 14,684 01 Jan 2026 Direct
Stephanie Monaghan O'Brien APLS Common Stock Award 45% 7,961 25,666 01 Jan 2026 Direct
Stephanie Monaghan O'Brien APLS Stock Option (Right to Buy) Award 14,684 14,684 01 Jan 2026 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.